Phonetica

Disease Detection Using Speech Analytics

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in June 2015 by Ron Shamir, Phonetica operates with 1–10 employees. The company has secured funding across one disclosed round, with its Seed round occurring in May 2016.

Business overview

Phonetica is a health tech company focused on developing voice-based marker solutions for early medical diagnosis and continuous monitoring of patients with chronic diseases. The company's core technology leverages vocal biomarkers to create an early alert system for emerging illness symptoms. Phonetica primarily serves the digital healthcare market, operating within the broader Health Tech & Life Sciences sector with a business model targeting B2C customers.

Log in to access full profile

Company Intelligence Q&A

What is Phonetica's primary focus?
Phonetica focuses on disease detection and patient monitoring through speech analytics, developing voice-based marker solutions for early medical diagnosis and chronic disease management.
When was Phonetica founded?
Phonetica was founded in June 2015.
Who is a key founder of Phonetica?
Ron Shamir is a co-founder and CEO of Phonetica.
What is Phonetica's product development stage?
Phonetica's products are currently in the R&D stage, as of May 2016 when the company secured its seed funding.
What is Phonetica's primary sector?
Phonetica operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Medical Diagnostics.
Log in to access full profile